All four specimens showed complete loss of SMARCA4 (BRG1) in the tumor nuclei, with endothelial and inflammatory cells as internal positive controls (Figs. 1, 2, 3 and 4), and showed negative expression of epithelial markers, including PCK, EMA and/or CK7. Here, SMARCA4 is linked to neoplasm.